All Stories

  1. Advancing Pediatric Dose Scaling: Strategies, Modeling Approaches, and Clinical Applications

    Article • Pharmaceuticals, July 2026, MDPI AG

    Dr Catherine Sherwin

  2. Resveratrol-Loaded Nanocarriers for Bone and Periodontal Regeneration: A Systematic Review

    Article • Current Pharmaceutical Biotechnology, April 2026, Bentham Science Publishers

    Dr Catherine Sherwin

  3. Mechanistic Effects of Propofol against Renal-ischemia Reperfusion Injury: A Systematic Review

    Article • Current Drug Research Reviews, March 2026, Bentham Science Publishers

    Dr Catherine Sherwin

  4. Possible involvement of keratinocyte‐derived microvesicle particles in human photosensitivity disorders

    Article • Photochemistry and Photobiology, November 2025, Wiley

    Dr Catherine Sherwin

  5. The Biological Effects of Soy Isoflavones against Myocardial Ischemia-reperfusion Injuries: A Systematic Review

    Article • The Natural Products Journal, November 2025, Bentham Science Publishers

    Dr Catherine Sherwin

  6. Pharmacokinetic profiles of sertraline in pregnancy as a predictor of postpartum depressive symptoms

    Article • British Journal of Clinical Pharmacology, October 2025, Wiley

    Dr Catherine Sherwin

  7. Possible involvement of keratinocyte-derived microvesicle particles in human photosensitivity disorders

    Article • September 2025, Cold Spring Harbor Laboratory Press

    Dr Catherine Sherwin

  8. The Effects of Resveratrol on Menopausal Cardio-metabolic Changes: A Systematic Review

    Article • Cardiovascular & Haematological Disorders - Drug Targets, September 2025, Bentham Science Publishers

    Dr Catherine Sherwin

  9. A Novel Maturation Equation for Hepatic Clearance Across Preterm, Term Neonates, Children, and Adults: Application to Paracetamol and Its Metabolite

    Article • The Journal of Clinical Pharmacology, September 2025, Wiley

    Dr Catherine Sherwin, Professor karel allegaert

  10. Anti-Cancer Effects of Soy Isoflavones against Cancer by Radiosensitizing Properties: A Systematic Review

    Article • Current Cancer Therapy Reviews, July 2025, Bentham Science Publishers

    Dr Catherine Sherwin

  11. The Relationship between Statin Intake and Risk of Pancreatic Cancer: A Systematic Review and Meta-analysis

    Article • Current Drug Research Reviews, July 2025, Bentham Science Publishers

    Dr Catherine Sherwin

  12. Emerging Therapeutic Potential of Fisetin for Nephrotoxicity, Kidney Injury, and Nephropathy: A Systematic Review

    Article • Current Diabetes Reviews, June 2025, Bentham Science Publishers

    Dr Catherine Sherwin

  13. Modernizing Preclinical Drug Development: The Role of New Approach Methodologies

    Article • ACS Pharmacology & Translational Science, May 2025, American Chemical Society (ACS)

    Dr Catherine Sherwin

  14. Vancomycin dosing in neonates: enhancing outcomes using population pharmacokinetics and simulation

    Article • Frontiers in Antibiotics, May 2025, Frontiers

    Professor karel allegaert , Dr Catherine Sherwin

  15. The Association between Gallstone Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis

    Article • Reviews on Recent Clinical Trials, May 2025, Bentham Science Publishers

    Dr Catherine Sherwin

  16. The Biological Effects of Nano-Curcumins against Drugs and Chemicals-Induced Nephrotoxicity: A Systematic Review

    Article • Current Pharmaceutical Biotechnology, April 2025, Bentham Science Publishers

    Dr Catherine Sherwin

  17. Chrysin and Bone Health: A Systematic Review of its Role in Bone Regeneration, Density, and Mass Enhancement

    Article • The Natural Products Journal, April 2025, Bentham Science Publishers

    Dr Catherine Sherwin

  18. Mechanistic Effects and Complications of Berberine on Cardiac Arrhythmias: A Systematic Review

    Article • Current Reviews in Clinical and Experimental Pharmacology, April 2025, Bentham Science Publishers

    Dr Catherine Sherwin

  19. The Special Issue “The 20th Anniversary of Pharmaceuticals—Multi-Targeted Natural Products as Therapeutics” Editorial—Multi-Targeted Therapeutics from Natural Sources: What Do We Know?

    Article • Pharmaceuticals, March 2025, MDPI AG

    Dr Catherine Sherwin

  20. Advances in Radiation Therapy Enhancement and Radio-Protection By Nano-Curcumins: A Systematic Review

    Article • Current Cancer Drug Targets, March 2025, Bentham Science Publishers

    Dr Catherine Sherwin

  21. Pharmacokinetic effect of disease severity and use of extracorporeal membrane oxygenation in critically ill Asian patients receiving vancomycin

    Article • Frontiers in Pharmacology, February 2025, Frontiers

    Dr Catherine Sherwin

  22. The Association between use of Renin-Angiotensin-Aldosterone System Inhibitors and the Risk and Mortality of Pancreatic Cancer: A Systematic Review and Meta-Analysis

    Article • Current Reviews in Clinical and Experimental Pharmacology, February 2025, Bentham Science Publishers

    Dr Catherine Sherwin

  23. Prediction of lacosamide concentrations to support dose optimization during pregnancy

    Article • Epilepsia, December 2024, Wiley

    Dr Catherine Sherwin

  24. Anti-seizure Effects and Mechanisms of Berberine: A Systematic Review

    Article • Current Pharmaceutical Biotechnology, December 2024, Bentham Science Publishers

    Dr Catherine Sherwin

  25. Association Between Gallstone Disease and Kidney Stone Disease: A Systematic Review and Meta-analysis

    Article • Epidemiology and Health System Journal, November 2024, MaadRayan Publishing Company

    Dr Catherine Sherwin

  26. The Effects and Safety of Silymarin on β-thalassemia in Children and Adolescents: A Systematic Review based on Clinical Trial Studies

    Article • Reviews on Recent Clinical Trials, November 2024, Bentham Science Publishers

    Dr Catherine Sherwin

  27. Efficacy and Mechanisms of Silybum Marianum, Silymarin, and Silibinin on Rheumatoid Arthritis and Osteoarthritis Symptoms: A Systematic Review

    Article • Current Rheumatology Reviews, September 2024, Bentham Science Publishers

    Dr Catherine Sherwin

  28. Bioequivalence of four oral prednisolone formulations in children with asthma or asthma-like exacerbations

    Article • August 2024, Wiley

    Dr Catherine Sherwin

  29. The Association between Statins Intake and Risk of Post Stroke Pneumonia: A Systematic Review and Meta-Analysis

    Article • Current Reviews in Clinical and Experimental Pharmacology, August 2024, Bentham Science Publishers

    Dr Catherine Sherwin

  30. A Systematic Review and Meta-analysis of the Relationship between Statin Intake and Esophageal Cancer

    Article • Anti-Cancer Agents in Medicinal Chemistry, August 2024, Bentham Science Publishers

    Dr Catherine Sherwin

  31. Radiotherapy Enhancing and Radioprotective Properties of Berberine: A Systematic Review

    Article • Recent Patents on Anti-Cancer Drug Discovery, July 2024, Bentham Science Publishers

    Dr Catherine Sherwin

  32. The Therapeutic Effects of Bromelain against Colorectal Cancer: A Systematic Review

    Article • Current Cancer Therapy Reviews, July 2024, Bentham Science Publishers

    Dr Catherine Sherwin

  33. When will the Glomerular Filtration Rate in Former Preterm Neonates Catch up with Their Term Peers?

    Article • Pharmaceutical Research, March 2024, Springer Science + Business Media

    Professor karel allegaert , Dr Catherine Sherwin

  34. Effect of Probiotics on Urinary Tract Infections in Children: A Systematic Review and Meta-Analysis

    Article • Current Reviews in Clinical and Experimental Pharmacology, March 2024, Bentham Science Publishers

    Dr Catherine Sherwin

  35. The Analgesic Effect of Ginger on Postoperative Pain: A Systematic Review of Clinical Trials

    Article • The Natural Products Journal, March 2024, Bentham Science Publishers

    Dr Catherine Sherwin

  36. Association Between Gallstone Disease and Risk of Mortality of Cardiovascular Disease and Cancer: A Systematic Review and Meta-Analysis

    Article • Cardiovascular & Haematological Disorders - Drug Targets, March 2024, Bentham Science Publishers

    Dr Catherine Sherwin

  37. Effects of Curcuma longa (turmeric) and curcumin on the premenstrual syndrome and dysmenorrhea: A systematic review

    Article • Journal of Endometriosis and Pelvic Pain Disorders, January 2024, SAGE Publications

    Dr Catherine Sherwin

  38. A physiological approach to renal clearance: From premature neonates to adults

    Article • British Journal of Clinical Pharmacology, January 2024, Wiley

    Professor karel allegaert , Dr Catherine Sherwin

  39. The survey of antitumor effects of bromelain on neoplastic breast cells: A systematic review

    Article • Journal of Herbmed Pharmacology, January 2024, MaadRayan Publishing Company

    Dr Catherine Sherwin

  40. Effect and Mechanism of Curcumin on Bone Loss and Osteoporosis: A Systematic Review

    Article • Current Traditional Medicine, December 2023, Bentham Science Publishers

    Dr Catherine Sherwin

  41. Neuroprotective Effects of Bromelain on the Common Neurodegenerative Diseases: A Systematic Review

    Article • Neurochemical Journal, December 2023, Pleiades Publishing Ltd

    Dr Catherine Sherwin

  42. A Systematic Review and Meta-analysis on the Role of Statins in the Prevention of Mortality Following Pancreatic Cancer

    Article • Anti-Cancer Agents in Medicinal Chemistry, November 2023, Bentham Science Publishers

    Dr Catherine Sherwin

  43. Multi-dose enteral L-citrulline administration in premature infants at risk of developing pulmonary hypertension associated with bronchopulmonary dysplasia

    Article • Perinatal Journal, October 2023, Springer Science + Business Media

    Dr Catherine Sherwin

  44. Editorial: Genetics and ontogeny in precision therapeutics for children

    Article • Frontiers in Genetics, October 2023, Frontiers

    Dr Catherine Sherwin

  45. Modulation of Hepatic Functions by Chicory (Cichorium intybus L.) Extract: Preclinical Study in Rats

    Article • Pharmaceuticals, October 2023, MDPI AG

    Dr Catherine Sherwin

  46. A perspective on In vitro developmental neurotoxicity test assay results: An expert panel review

    Article • Regulatory Toxicology and Pharmacology, September 2023, Elsevier

    Dr Catherine Sherwin

  47. The Role of Vitamin D in Carpal Tunnel Syndrome Risk and Supplementation Outcomes: A Systematic Review

    Article • Current Rheumatology Reviews, August 2023, Bentham Science Publishers

    Dr Catherine Sherwin

  48. Effect of Curcumin on Oxidative Stress, Inflammatory Response and Kidney Biochemical Parameters Among Kidney Disease Patients: A Systematic Review

    Article • The Natural Products Journal, August 2023, Bentham Science Publishers

    Dr Catherine Sherwin

  49. Pharmacokinetics and safety of prolonged paracetamol treatment in neonates: An interventional cohort study

    Article • British Journal of Clinical Pharmacology, July 2023, Wiley

    Dr Catherine Sherwin

  50. Topical Photodynamic Therapy Generates Bioactive Microvesicle Particles: Evidence for a Pathway Involved in Immunosuppressive Effects

    Article • Journal of Investigative Dermatology, July 2023, Elsevier

    Benjamin Schmeusser, Dr Catherine Sherwin

  51. The Effect of Inhalation Aromatherapy on Patients with Cardiovascular Disease Seeking Pain Relief: A Systematic Review and Meta-analysis

    Article • Current Drug Therapy, June 2023, Bentham Science Publishers

    Dr Catherine Sherwin, Razieh Mohammadi

  52. Editorial: Methods and protocols in obstetric and pediatric pharmacology: 2022

    Article • Frontiers in Pharmacology, May 2023, Frontiers

    Dr Catherine Sherwin

  53. Editorial: Women in obstetric and pediatric pharmacology: 2021

    Article • Frontiers in Pharmacology, April 2023, Frontiers

    Dr Catherine Sherwin

  54. Vancomycin Clearance in Obese Adults is not Predictive of Clearance in Obese Adolescents

    Article • Clinical Pharmacokinetics, April 2023, Springer Science + Business Media

    Dr Catherine Sherwin

  55. Drug exposure during pregnancy: Current understanding and approaches to measure maternal-fetal drug exposure

    Article • Frontiers in Pharmacology, March 2023, Frontiers

    Dr Catherine Sherwin

  56. Current use of complementary and conventional medicine for treatment of pediatric patients with gastrointestinal disorders

    Article • Frontiers in Pharmacology, January 2023, Frontiers

    Dr Catherine Sherwin

  57. Assessment of the Relationship Between Gastric-Acid Suppressants and the Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis

    Article • Current Therapeutic Research, January 2023, Elsevier

    Dr Catherine Sherwin

  58. Editorial: Publishing in 2023 and Beyond

    Article • Current Therapeutic Research, January 2023, Elsevier

    Dr Catherine Sherwin

  59. Management of Anti-Seizure Medications during Pregnancy: Advancements in The Past Decade

    Article • Pharmaceutics, December 2022, MDPI AG

    Dr Catherine Sherwin

  60. Pharmacokinetics of l-Citrulline in Neonates at Risk of Developing Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension

    Article • Pediatric Drugs, October 2022, Springer Science + Business Media

    Dr Catherine Sherwin

  61. Exploring the Past to Inform the Future to Optimize the Pharmacokinetics of Vancomycin in Children With Severe Burn Injuries

    Article • Journal of Burn Care & Research, October 2022, Oxford University Press (OUP)

    Dr Catherine Sherwin

  62. Optimal dosing of enoxaparin in overweight and obese children

    Article • British Journal of Clinical Pharmacology, July 2022, Wiley

    Dr Catherine Sherwin

  63. Relationship between serum vitamin D and hip fracture in the elderly: a systematic review and meta-analysis

    Article • Journal of Bone and Mineral Metabolism, May 2022, Springer Science + Business Media

    Dr Catherine Sherwin

  64. Effectiveness of phosphodiesterase type 5 inhibitors on the treatment of thin endometrium and pregnancy outcomes: An systematic review

    Article • Journal of Endometriosis and Pelvic Pain Disorders, May 2022, SAGE Publications

    Dr Catherine Sherwin

  65. Examination of Complementary Medicine for Treating Urinary Tract Infections Among Pregnant Women and Children

    Article • Frontiers in Pharmacology, April 2022, Frontiers

    Dr Catherine Sherwin

  66. Effects and Mechanisms of Medicinal Plants on Healing Scars: A Systematic Review

    Article • Current Traditional Medicine, February 2022, Bentham Science Publishers

    Dr Catherine Sherwin

  67. Valuable Hepatoprotective Plants - How Can We Optimize Waste Free Uses of Such Highly Versatile Resources?

    Article • Frontiers in Pharmacology, November 2021, Frontiers

    Dr Catherine Sherwin

  68. Evidence for Systemic Reactive Oxygen Species in UVB‐mediated Microvesicle Formation

    Article • Photochemistry and Photobiology, August 2021, Wiley

    Benjamin Schmeusser, Dr Catherine Sherwin

  69. Effects of Medicinal Plants on Human Hosts and Zoonotic Helminthic Infections: A Systematic Review

    Article • The Natural Products Journal, August 2021, Bentham Science Publishers

    Dr Catherine Sherwin

  70. Maternal Exposure and Neonatal Effects of Drugs of Abuse

    Article • The Journal of Clinical Pharmacology, August 2021, Wiley

    Dr Catherine Sherwin

  71. Pharmacokinetics of Ceftazidime in Children and Adolescents with Obesity

    Article • Pediatric Drugs, July 2021, Springer Science + Business Media

    Dr Catherine Sherwin

  72. Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipients

    Article • Expert Opinion on Drug Metabolism & Toxicology, June 2021, Taylor & Francis

    Dr Catherine Sherwin

  73. Oral drug dosing following bariatric surgery: General concepts and specific dosing advice

    Article • British Journal of Clinical Pharmacology, June 2021, Wiley

    Dr Catherine Sherwin

  74. Dosing Recommendations for Vancomycin in Children and Adolescents with Varying Levels of Obesity and Renal Dysfunction: a Population Pharmacokinetic Study in 1892 Children Aged 1–18 Years

    Article • The AAPS Journal, April 2021, Springer Science + Business Media

    Dr Catherine Sherwin

  75. Effects of a new thyrotropic drug isolated from Potentilla alba on the male reproductive system of rats and offspring development

    Article • BMC Complementary Medicine and Therapies, January 2021, Springer Science + Business Media

    Dr Catherine Sherwin

  76. Creatinine‐Based Renal Function Assessment in Pediatric Drug Development: An Analysis Using Clinical Data for Renally Eliminated Drugs

    Article • Clinical Pharmacology & Therapeutics, August 2020, Wiley

    Dr Catherine Sherwin

  77. How can we improve the safe use of herbal medicine and other natural products? A clinical pharmacologist mission

    Article • Expert Review of Clinical Pharmacology, August 2020, Taylor & Francis

    Dr Catherine Sherwin

  78. Population pharmacokinetics of olanzapine in children

    Article • British Journal of Clinical Pharmacology, July 2020, Wiley

    Dr Catherine Sherwin

  79. Spotlight Commentary: Why we need to pay attention to toxicity associated with herbal medicines

    Article • British Journal of Clinical Pharmacology, May 2020, Wiley

    Dr Catherine Sherwin

  80. Supportive care medications coinciding with chemotherapy among children with hematologic malignancy

    Article • Leukemia & Lymphoma, April 2020, Taylor & Francis

    Dr Catherine Sherwin

  81. Investigation into the reproducibility of the association of cord blood magnesium concentration and cerebral palsy or death in children

    Article • March 2020, Research Square

    Dr Catherine Sherwin

  82. The Reliability of Histamine Pharmacodynamic Response Phenotype Classification in Children With Allergic Disease

    Article • Frontiers in Pharmacology, March 2020, Frontiers

    Dr Catherine Sherwin

  83. Therapeutic Potential of Citrulline as an Arginine Supplement: A Clinical Pharmacology Review

    Article • Pediatric Drugs, March 2020, Springer Science + Business Media

    Dr Catherine Sherwin

  84. Use of Herbal Medicine by Pregnant Women: What Physicians Need to Know

    Article • Frontiers in Pharmacology, January 2020, Frontiers

    Dr Catherine Sherwin

  85. Changing trends in IVIG use in pediatric patients: A retrospective review of practices in a network of major USA pediatric hospitals

    Article • International Immunopharmacology, November 2019, Elsevier

    Dr Catherine Sherwin

  86. Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches

    Article • Cancers, October 2019, MDPI AG

    Dr Catherine Sherwin

  87. A Phase 1 Study of Intravenous Busulfan as a Conditioning Regimen for Multiple Myeloma

    Article • Cell Transplantation, October 2019, SAGE Publications

    Dr Catherine Sherwin

  88. Antibiotic Treatment of Suspected and Confirmed Neonatal Sepsis Within 28 Days of Birth: A Retrospective Analysis

    Article • Frontiers in Pharmacology, October 2019, Frontiers

    Dr Catherine Sherwin

  89. Development of a neonatal adverse event severity scale through a Delphi consensus approach

    Article • Archives of Disease in Childhood, September 2019, BMJ

    Professor karel allegaert , Dr Catherine Sherwin

  90. Population Pharmacokinetic Modeling of Gentamicin in Pediatrics

    Article • The Journal of Clinical Pharmacology, July 2019, Wiley

    Dr Catherine Sherwin

  91. Generic drug products in paediatrics: Where are the data?

    Article • British Journal of Clinical Pharmacology, July 2019, Wiley

    Dr Catherine Sherwin

  92. Cost-Sharing Requirements for the Herpes Zoster Vaccine in Adults Aged 60+

    Article • Journal of Pharmacy Technology, July 2019, SAGE Publications

    Dr Catherine Sherwin

  93. Population Pharmacokinetic Modeling in the Presence of Missing Time-Dependent Covariates: Impact of Body Weight on Pharmacokinetics of Paracetamol in Neonates

    Article • The AAPS Journal, May 2019, Springer Science + Business Media

    Professor karel allegaert , Dr Catherine Sherwin

  94. Development and validation of an assay for quantifying budesonide in dried blood spots collected from extremely low gestational age neonates

    Article • Journal of Pharmaceutical and Biomedical Analysis, April 2019, Elsevier

    Dr Catherine Sherwin

  95. Glucocorticoids pharmacology and their application in the treatment of childhood-onset systemic lupus erythematosus

    Article • Seminars in Arthritis and Rheumatism, March 2019, Elsevier

    Dr Catherine Sherwin

  96. Renal Clearance in Newborns and Infants: Predictive Performance of Population‐Based Modeling for Drug Development

    Article • Clinical Pharmacology & Therapeutics, February 2019, Wiley

    Dr Catherine Sherwin

  97. Cost‐effectiveness of early cancer surveillance for patients with Li–Fraumeni syndrome

    Article • Pediatric Blood & Cancer, February 2019, Wiley

    Dr Catherine Sherwin

  98. Impact of Disease on Amikacin Pharmacokinetics and Dosing in Children

    Article • Therapeutic Drug Monitoring, February 2019, Wolters Kluwer Health

    Professor karel allegaert , Dr Catherine Sherwin

  99. The effect of a prescription order requirement for pharmacist-administered vaccination on herpes zoster vaccination rates

    Article • Vaccine, January 2019, Elsevier

    Dr Catherine Sherwin

  100. Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents

    Article • BMC Pharmacology and Toxicology, December 2018, Springer Science + Business Media

    Dr Catherine Sherwin

  101. An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin-Resistant Staphylococcus aureus

    Article • The Journal of Clinical Pharmacology, October 2018, Wiley

    Dr Catherine Sherwin

  102. Identification of Cytochrome P450 Polymorphisms in Burn Patients and Impact on Fentanyl Pharmacokinetics: A Pilot Study

    Article • Journal of Burn Care & Research, October 2018, Oxford University Press (OUP)

    Dr Catherine Sherwin

  103. Prospective study of serum and ionized magnesium pharmacokinetics in the treatment of children with severe acute asthma

    Article • European Journal of Clinical Pharmacology, September 2018, Springer Science + Business Media

    Dr Catherine Sherwin

  104. Population Pharmacokinetics of Amikacin in Adult Patients with Cystic Fibrosis

    Article • Antimicrobial Agents and Chemotherapy, July 2018, ASM Journals

    Theodore Liou, Dr Catherine Sherwin

  105. State-of-the-Art Review on Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development

    Article • Clinical Pharmacokinetics, May 2018, Springer Science + Business Media

    Dr Shaun S Kumar, Dr Catherine Sherwin

  106. The clinical utility of pharmacometric models

    Article • British Journal of Clinical Pharmacology, May 2018, Wiley

    Dr Catherine Sherwin, Dr Shaun S Kumar

  107. Evident bias in a paracetamol metabolite population pharmacokinetic model applied to an external dataset

    Article • British Journal of Clinical Pharmacology, April 2018, Wiley

    Dr Catherine Sherwin

  108. Polymorphic Expression of UGT1A9 is Associated with Variable Acetaminophen Glucuronidation in Neonates: A Population Pharmacokinetic and Pharmacogenetic Study

    Article • Clinical Pharmacokinetics, April 2018, Springer Science + Business Media

    Dr Shaun S Kumar, Dr Catherine Sherwin

  109. Clinical Pharmacokinetics of Amikacin in Pediatric Patients: A Comprehensive Review of Population Pharmacokinetic Analyses

    Article • Clinical Pharmacokinetics, March 2018, Springer Science + Business Media

    Dr Catherine Sherwin

  110. Inclusion of pregnant and breastfeeding women in research - efforts and initiatives

    Article • British Journal of Clinical Pharmacology, October 2017, Wiley

    Dr Catherine Sherwin

  111. Predicting tacrolimus concentrations in children receiving a heart transplant using a population pharmacokinetic model

    Article • BMJ Paediatrics Open, October 2017, BMJ

    Dr Catherine Sherwin, Dr Shaun S Kumar

  112. The Need for Pediatric Drug Development

    Article • The Journal of Pediatrics, September 2017, Elsevier

    Dr Catherine Sherwin

  113. Phytotherapy as an alternative to conventional antimicrobials: combating microbial resistance

    Article • Expert Review of Clinical Pharmacology, August 2017, Taylor & Francis

    Dr Catherine Sherwin

  114. Riding (High) into the danger zone: a review of potential differences in chemical exposures in fighter pilots resulting from high altitude and G-forces

    Article • Expert Opinion on Drug Metabolism & Toxicology, August 2017, Taylor & Francis

    Dr Catherine Sherwin

  115. Can ad hoc analyses of clinical trials help personalize treatment decisions?

    Article • British Journal of Clinical Pharmacology, August 2017, Wiley

    Dr Shaun S Kumar, Dr Catherine Sherwin, Shaun Kumar

  116. Population Pharmacokinetic Model of Transdermal Nicotine Delivered from a Matrix-Type Patch

    Article • British Journal of Clinical Pharmacology, August 2017, Wiley

    Dr Catherine Sherwin

  117. The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies

    Article • European Journal of Clinical Pharmacology, June 2017, Springer Science + Business Media

    Dr Catherine Sherwin

  118. Risk of nonsteroidal anti-inflammatory drug-associated renal dysfunction among neonates diagnosed with patent ductus arteriosus and treated with gentamicin

    Article • Perinatal Journal, June 2017, Springer Science + Business Media

    Dr Catherine Sherwin

  119. Analgesics commonly used to treat pediatric patients with malignancy.

    Article • Expert Opinion on Drug Metabolism & Toxicology, June 2017, Taylor & Francis

    Dr Catherine Sherwin

  120. Use of TEG/Platelet Mapping to Dose-Adjust Platelet Inhibitors in Children Supported with the Berlin EXCOR: In Search of a Correlation

    Article • The Journal of Heart and Lung Transplantation, April 2017, Elsevier

    Dr Catherine Sherwin

  121. Genetic Variation in the Histamine Production, Response, and Degradation Pathway Is Associated with Histamine Pharmacodynamic Response in Children with Asthma

    Article • Frontiers in Pharmacology, January 2017, Frontiers

    Dr Catherine Sherwin

  122. Hepatic Drug Metabolism in Pediatric Patients

    Article • January 2017, Elsevier

    Dr Catherine Sherwin

  123. Herbal Medicines: challenges in the modern world. Part 5. status and current directions of complementary and alternative herbal medicine worldwide

    Article • Expert Review of Clinical Pharmacology, December 2016, Taylor & Francis

    Dr Catherine Sherwin

  124. Clinical pharmacokinetics of magnesium sulfate in the treatment of children with severe acute asthma

    Article • European Journal of Clinical Pharmacology, December 2016, Springer Science + Business Media

    Dr Catherine Sherwin

  125. A Retrospective Study of the Impact of Rapid Diagnostic Testing on Time to Pathogen Identification and Antibiotic Use for Children with Positive Blood Cultures

    Article • Infectious Diseases and Therapy, November 2016, Springer Science + Business Media

    Dr Catherine Sherwin

  126. Herbal medicines: challenges in the modern world. Part 4. Canada and United States

    Article • Expert Review of Clinical Pharmacology, October 2016, Taylor & Francis

    Dr Catherine Sherwin

  127. Newborns still lack drug data to guide therapy

    Article • British Journal of Clinical Pharmacology, October 2016, Wiley

    Dr Catherine Sherwin

  128. Calls to a teratogen information service regarding potential exposures in pregnancy and breastfeeding

    Article • BMC Pharmacology and Toxicology, July 2016, Springer Science + Business Media

    Dr Catherine Sherwin

  129. Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections

    Article • Expert Review of Anti-infective Therapy, July 2016, Taylor & Francis

    Dr Catherine Sherwin

  130. AUC‐Guided Vancomycin Dosing in Adolescent Patients With Suspected Sepsis

    Article • The Journal of Clinical Pharmacology, July 2016, Wiley

    Dr Catherine Sherwin

  131. Clinical Pharmacokinetics and Pharmacodynamics of Biologic Therapeutics for Treatment of Systemic Lupus Erythematosus

    Article • Clinical Pharmacokinetics, July 2016, Springer Science + Business Media

    Dr Catherine Sherwin

  132. Optimizing enrollment in pediatric obese patients: reflections on recruitment characteristics

    Article • International Journal of Adolescent Medicine and Health, July 2016, De Gruyter

    Dr Catherine Sherwin

  133. Population pharmacokinetic/pharmacodynamic modeling of histamine response measured by histamine iontophoresis laser Doppler

    Article • Journal of Pharmacokinetics and Pharmacodynamics, June 2016, Springer Science + Business Media

    Dr Catherine Sherwin

  134. Herbal medicines: challenges in the modern world. Part 3. China and Japan

    Article • Expert Review of Clinical Pharmacology, June 2016, Taylor & Francis

    Dr Catherine Sherwin

  135. Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates

    Article • BMC Pharmacology and Toxicology, June 2016, Springer Science + Business Media

    Dr Catherine Sherwin

  136. Use of Oxandrolone to Promote Growth in Neonates following Surgery for Complex Congenital Heart Disease: An Open-Label Pilot Trial

    Article • Congenital Heart Disease, June 2016, Computers, Materials and Continua (Tech Science Press)

    Dr Catherine Sherwin

  137. Salivary caffeine concentrations are comparable to plasma concentrations in preterm infants receiving extended caffeine therapy

    Article • British Journal of Clinical Pharmacology, June 2016, Wiley

    Dr Catherine Sherwin

  138. Unanswered Questions Regarding Optimal Pediatric Vancomycin Use

    Article • Therapeutic Drug Monitoring, June 2016, Wolters Kluwer Health

    Dr Catherine Sherwin

  139. Herbal medicines: challenges in the modern world. Part 2. European Union and Russia

    Article • Expert Review of Clinical Pharmacology, May 2016, Taylor & Francis

    Dr Catherine Sherwin

  140. Optimizing the use of intravenous magnesium sulfate for acute asthma treatment in children

    Article • Pediatric Pulmonology, May 2016, Wiley

    Dr Catherine Sherwin

  141. Neonatal Maturation of Paracetamol (Acetaminophen) Glucuronidation, Sulfation, and Oxidation Based on a Parent–Metabolite Population Pharmacokinetic Model

    Article • Clinical Pharmacokinetics, May 2016, Springer Science + Business Media

    Dr Catherine Sherwin

  142. Herbal medicines: challenges in the modern world. Part 1. Australia and New Zealand

    Article • Expert Review of Clinical Pharmacology, April 2016, Taylor & Francis

    Dr Catherine Sherwin

  143. Therapeutic Drug Monitoring of Ganciclovir Treatment for Cytomegalovirus Infections Among Immunocompromised Children

    Article • Journal of the Pediatric Infectious Diseases Society, March 2016, Oxford University Press (OUP)

    Dr Catherine Sherwin

  144. Comparison of the New Adult Ventilator-Associated Event Criteria to the Centers for Disease Control and Prevention Pediatric Ventilator-Associated Pneumonia Definition (PNU2) in a Population of Pediatric Traumatic Brain Injury Patients*

    Article • Pediatric Critical Care Medicine, February 2016, Wolters Kluwer Health

    Dr Catherine Sherwin

  145. Neonates and medicines: a roadmap to further improve neonatal pharmaceutical care

    Article • European Journal of Pediatrics, January 2016, Springer Science + Business Media

    Dr Catherine Sherwin, Professor karel allegaert

  146. Therapeutic Drug Monitoring in Pregnancy

    Article • January 2016, Elsevier

    Dr Catherine Sherwin

  147. Pregnancy-induced changes in the pharmacokinetics of caffeine and its metabolites

    Article • The Journal of Clinical Pharmacology, December 2015, Wiley

    Dr Catherine Sherwin

  148. Renal Function Descriptors in Neonates: Which Creatinine-Based Formula Best Describes Vancomycin Clearance?

    Article • The Journal of Clinical Pharmacology, December 2015, Wiley

    Dr Catherine Sherwin

  149. Towards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling

    Article • Antimicrobial Agents and Chemotherapy, December 2015, ASM Journals

    Dr Catherine Sherwin, Professor karel allegaert

  150. Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration–Time Curve to the Minimum Inhibitory Concentration ≥400 Target

    Article • Therapeutic Drug Monitoring, December 2015, Wolters Kluwer Health

    Dr Catherine Sherwin

  151. Pharmacokinetic considerations in the use of antivirals in neonates

    Article • Expert Opinion on Drug Metabolism & Toxicology, November 2015, Informa Healthcare

    Dr Catherine Sherwin

  152. Use of Modeling and Simulation in the Design and Conduct of Pediatric Clinical Trials and the Optimization of Individualized Dosing Regimens

    Article • CPT Pharmacometrics & Systems Pharmacology, November 2015, Wiley

    Dr Catherine Sherwin

  153. A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates

    Article • Archives of Disease in Childhood Fetal & Neonatal, September 2015, BMJ

    Dr Catherine Sherwin

  154. A Population Pharmacokinetic Analysis of Dextroamphetamine in the Plasma and Hair of Healthy Adults

    Article • Clinical Drug Investigation, September 2015, Springer Science + Business Media

    Dr Catherine Sherwin

  155. Challenges Associated with Route of Administration in Neonatal Drug Delivery

    Article • Clinical Pharmacokinetics, August 2015, Springer Science + Business Media

    Dr Catherine Sherwin

  156. Effect of CYP3A5*3 on asthma control among children treated with inhaled beclomethasone

    Article • Journal of Allergy and Clinical Immunology, August 2015, Elsevier

    Dr Catherine Sherwin

  157. Population Pharmacokinetics of Intravenous Paracetamol (Acetaminophen) in Preterm and Term Neonates: Model Development and External Evaluation

    Article • Clinical Pharmacokinetics, July 2015, Springer Science + Business Media

    Professor karel allegaert , Dr Catherine Sherwin

  158. Pharmacokinetic modeling of therapies for systemic lupus erythematosus

    Article • Expert Review of Clinical Pharmacology, July 2015, Taylor & Francis

    Dr Catherine Sherwin

  159. National Trends in the Incidence, Outcomes and Charges of Pediatric Osteoarticular Infections, 1997–2012

    Article • The Pediatric Infectious Disease Journal, June 2015, Wolters Kluwer Health

    Dr Catherine Sherwin

  160. Economic Analysis of Rapid and Sensitive Polymerase Chain Reaction Testing in the Emergency Department for Influenza Infections in Children

    Article • The Pediatric Infectious Disease Journal, June 2015, Wolters Kluwer Health

    Dr Catherine Sherwin

  161. Quantitative Assay Validation for Oxandrolone in Human Plasma Using LC–MS-MS

    Article • Journal of Analytical Toxicology, May 2015, Oxford University Press (OUP)

    Dr Catherine Sherwin

  162. Predictive Performance of a Vancomycin Population Pharmacokinetic Model in Neonates

    Article • Infectious Diseases and Therapy, May 2015, Springer Science + Business Media

    Dr Catherine Sherwin

  163. Darbepoetin administration to neonates undergoing cooling for encephalopathy: a safety and pharmacokinetic trial

    Article • Pediatric Research, May 2015, Springer Science + Business Media

    Dr Catherine Sherwin

  164. Population Pharmacokinetics of Darbepoetin Alfa in Conjunction with Hypothermia for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy

    Article • Clinical Pharmacokinetics, May 2015, Springer Science + Business Media

    Dr Catherine Sherwin

  165. Application of a method used to deconstruct a single dose pharmacokinetic profile from multiple dose data

    Article • Biopharmaceutics & Drug Disposition, April 2015, Wiley

    Dr Catherine Sherwin

  166. Special population considerations and regulatory affairs for clinical research

    Article • Clinical Research and Regulatory Affairs, April 2015, Taylor & Francis

    Dr Catherine Sherwin

  167. Clinical Pharmacokinetics of Inhaled Antimicrobials

    Article • Clinical Pharmacokinetics, March 2015, Springer Science + Business Media

    Dr Catherine Sherwin

  168. How well does physician selection of microbiologic tests identify Clostridium difficile and other pathogens in paediatric diarrhoea? Insights using multiplex PCR-based detection

    Article • Clinical Microbiology and Infection, February 2015, Elsevier

    Dr Catherine Sherwin

  169. Optimal design in pediatric pharmacokinetic and pharmacodynamic clinical studies

    Article • Pediatric Anesthesia, January 2015, Wiley

    Dr Catherine Sherwin

  170. Determination of Optimal Amikacin Dosing Regimens for Pediatric Patients With Burn Wound Sepsis

    Article • Journal of Burn Care & Research, January 2015, Oxford University Press (OUP)

    Dr Catherine Sherwin

  171. Relationship Between Zolpidem Concentrations and Sleep Parameters in Pediatric Burn Patients

    Article • Journal of Burn Care & Research, January 2015, Oxford University Press (OUP)

    Dr Catherine Sherwin

  172. Outpatient Parenteral Antimicrobial Therapy in Pediatrics: An Opportunity to Expand Antimicrobial Stewardship

    Article • Infection Control, December 2014, Cambridge University Press

    Dr Catherine Sherwin

  173. An extensive pharmacokinetic, metabolic and toxicological review of elderly patients under intensive chemotherapy for acute myeloid leukemia

    Article • Expert Opinion on Drug Metabolism & Toxicology, December 2014, Informa Healthcare

    Dr Catherine Sherwin

  174. Rate of asthma trial outcomes reporting on ClinicalTrials.gov and in the published literature

    Article • Journal of Allergy and Clinical Immunology, December 2014, Elsevier

    Dr Catherine Sherwin

  175. Clinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection

    Article • Expert Opinion on Drug Metabolism & Toxicology, November 2014, Informa Healthcare

    Dr Catherine Sherwin

  176. Levofloxacin inhalation solution for the treatment of chronicPseudomonas aeruginosainfection among patients with cystic fibrosis

    Article • Expert Review of Respiratory Medicine, November 2014, Taylor & Francis

    Dr Catherine Sherwin

  177. Pediatric vancomycin dosing: Trends over time and the impact of therapeutic drug monitoring

    Article • The Journal of Clinical Pharmacology, November 2014, Wiley

    Dr Catherine Sherwin

  178. Neonatal Magnesium Levels Correlate with Motor Outcomes in Premature Infants: A Long-Term Retrospective Cohort Study

    Article • Frontiers in Pediatrics, November 2014, Frontiers

    Dr Catherine Sherwin

  179. Illustrative neonatal cases regarding drug delivery issues

    Article • Journal of Paediatrics and Child Health, November 2014, Wiley

    Dr Catherine Sherwin

  180. Ethics of Drug Studies in the Newborn

    Article • Pediatric Drugs, October 2014, Springer Science + Business Media

    Dr Catherine Sherwin

  181. Vancomycin pharmacokinetic models: informing the clinical management of drug-resistant bacterial infections

    Article • Expert Review of Anti-infective Therapy, October 2014, Taylor & Francis

    Dr Catherine Sherwin

  182. Development of an optimal sampling schedule for children receiving ketamine for short-term procedural sedation and analgesia

    Article • Pediatric Anesthesia, September 2014, Wiley

    Dr Catherine Sherwin

  183. Intrapartum Magnesium Sulfate and the Potential for Cardiopulmonary Drug–Drug Interactions

    Article • Therapeutic Drug Monitoring, August 2014, Wolters Kluwer Health

    Dr Catherine Sherwin

  184. Appropriate prescribing for acute childhood infections

    Article • Paediatrics and International Child Health, July 2014, Taylor & Francis

    Dr Catherine Sherwin

  185. Epidemiological Evaluation of Blood Culture Patterns among Neonates Receiving Vancomycin

    Article • Indian Journal of Microbiology, June 2014, Springer Science + Business Media

    Dr Catherine Sherwin

  186. Preliminary Assessment of Zolpidem Pharmacokinetics in Pediatric Burn Patients

    Article • Therapeutic Drug Monitoring, June 2014, Wolters Kluwer Health

    Dr Catherine Sherwin

  187. Pharmacokinetics and Pharmacodynamics of Antibacterials, Antifungals, and Antivirals Used Most Frequently in Neonates and Infants

    Article • Clinical Pharmacokinetics, May 2014, Springer Science + Business Media

    Dr Catherine Sherwin

  188. Simultaneous Pharmacokinetic Modeling of Gentamicin, Tobramycin and Vancomycin Clearance from Neonates to Adults: Towards a Semi-physiological Function for Maturation in Glomerular Filtration

    Article • Pharmaceutical Research, May 2014, Springer Science + Business Media

    Professor karel allegaert , Dr Catherine Sherwin

  189. Pharmacokinetics and Pharmacodynamics of Antifungals in Children and their Clinical Implications

    Article • Clinical Pharmacokinetics, March 2014, Springer Science + Business Media

    Dr Catherine Sherwin

  190. Amikacin population pharmacokinetics among paediatric burn patients

    Article • Burns, March 2014, Elsevier

    Dr Catherine Sherwin

  191. Alignment of United States funding for cardiovascular disease research with deaths, years of life lost, and hospitalizations

    Article • International Journal of Cardiology, March 2014, Elsevier

    Dr Catherine Sherwin

  192. Evolution of interventional vancomycin trials in light of new antibiotic development in the USA, 1999–2012

    Article • International Journal of Antimicrobial Agents, March 2014, Elsevier

    Dr Catherine Sherwin

  193. Utilization of Optimal Study Design for Maternal and Fetal Sheep Propofol Pharmacokinetics Study: A Preliminary Study

    Article • Current Clinical Pharmacology, February 2014, Bentham Science Publishers

    Dr Catherine Sherwin

  194. Intravenous drug delivery in neonates: lessons learnt

    Article • Archives of Disease in Childhood, January 2014, BMJ

    Dr Catherine Sherwin

  195. Use of Methylxanthine Therapies for the Treatment and Prevention of Apnea of Prematurity

    Article • Pediatric Drugs, January 2014, Springer Science + Business Media

    Dr Catherine Sherwin

  196. Pharmacokinetic and pharmacodynamic optimisation of intravenous tobramycin dosing among children with cystic fibrosis

    Article • Journal of Pharmacokinetics and Pharmacodynamics, January 2014, Springer Science + Business Media

    Dr Catherine Sherwin

  197. Maternal Magnesium Sulphate Exposure Predicts Neonatal Magnesium Blood Concentrations

    Article • Basic & Clinical Pharmacology & Toxicology, December 2013, Wiley

    Dr Catherine Sherwin

  198. Development of levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis

    Article • Therapeutic Advances in Respiratory Disease, December 2013, SAGE Publications

    Dr Catherine Sherwin

  199. Absence of P-Glycoprotein Transport in the Pharmacokinetics and Toxicity of the Herbicide Paraquat

    Article • Journal of Pharmacology and Experimental Therapeutics, December 2013, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Catherine Sherwin

  200. Characteristics and publication patterns of obstetric studies registered in ClinicalTrials.gov

    Article • The Journal of Clinical Pharmacology, November 2013, Wiley

    Dr Catherine Sherwin

  201. Considerations in the Pharmacologic Treatment and Prevention of Neonatal Sepsis

    Article • Pediatric Drugs, November 2013, Springer Science + Business Media

    Dr Catherine Sherwin

  202. A Neonatal Amikacin Covariate Model Can Be Used to Predict Ontogeny of Other Drugs Eliminated Through Glomerular Filtration in Neonates

    Article • Pharmaceutical Research, September 2013, Springer Science + Business Media

    Professor karel allegaert , Dr Catherine Sherwin

  203. Optimization of anti‐pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides

    Article • Pediatric Pulmonology, September 2013, Wiley

    Dr Catherine Sherwin

  204. Characteristics of antimicrobial studies registered in the USA through ClinicalTrials.Gov

    Article • International Journal of Antimicrobial Agents, August 2013, Elsevier

    Dr Catherine Sherwin

  205. Population Pharmacokinetics of Intermittent Vancomycin in Children with Cystic Fibrosis

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, July 2013, Wiley

    Dr Catherine Sherwin

  206. Invasive Pneumococcal Disease in Infants Younger Than 90 Days Before and After Introduction of PCV7

    Article • PEDIATRICS, July 2013, American Academy of Pediatrics (AAP)

    Dr Catherine Sherwin

  207. Variability of Histamine Pharmacodynamic Response in Children With Allergic Rhinitis

    Article • The Journal of Clinical Pharmacology, May 2013, Wiley

    Dr Catherine Sherwin

  208. Seasonality of Acute Otitis Media and the Role of Respiratory Viral Activity in Children

    Article • The Pediatric Infectious Disease Journal, April 2013, Wolters Kluwer Health

    Dr Catherine Sherwin

  209. Prevalence of nematode infection and faecal egg counts in free-range laying hens: relations to housing and husbandry

    Article • British Poultry Science, February 2013, Taylor & Francis

    Dr Catherine Sherwin

  210. Optimization of anti‐pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary

    Article • Pediatric Pulmonology, January 2013, Wiley

    Dr Catherine Sherwin

  211. Bioequivalence and Bioavailability Clinical Trials: A Status Report from the National Institutes of Health ClinicalTrials.gov Registry

    Article • Journal of Bioequivalence & Bioavailability, January 2013, OMICS Publishing Group

    Dr Catherine Sherwin

  212. Population Pharmacokinetic Modeling of Risperidone and 9-Hydroxyrisperidone to Estimate CYP2D6 Subpopulations in Children and Adolescents

    Article • Therapeutic Drug Monitoring, October 2012, Wolters Kluwer Health

    Dr Catherine Sherwin

  213. Metabolic and toxicological considerations for sepsis drug treatments

    Article • Expert Opinion on Drug Metabolism & Toxicology, September 2012, Informa Healthcare

    Dr Catherine Sherwin

  214. Optimization of anti‐pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium

    Article • Pediatric Pulmonology, September 2012, Wiley

    Dr Catherine Sherwin

  215. Optimization of anti‐pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins

    Article • Pediatric Pulmonology, September 2012, Wiley

    Dr Catherine Sherwin

  216. Optimization of anti‐pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones

    Article • Pediatric Pulmonology, September 2012, Wiley

    Dr Catherine Sherwin

  217. Fundamentals of Population Pharmacokinetic Modelling

    Article • Clinical Pharmacokinetics, September 2012, Springer Science + Business Media

    Dr Catherine Sherwin

  218. Fundamentals of Population Pharmacokinetic Modelling

    Article • Clinical Pharmacokinetics, September 2012, Springer Science + Business Media

    Dr Catherine Sherwin

  219. Optimization of anti‐pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: I. aztreonam and carbapenems

    Article • Pediatric Pulmonology, August 2012, Wiley

    Dr Catherine Sherwin

  220. Fundamentals of Population Pharmacokinetic Modelling

    Article • Clinical Pharmacokinetics, August 2012, Springer Science + Business Media

    Dr Catherine Sherwin

  221. Fundamentals of Population Pharmacokinetic Modelling

    Article • Clinical Pharmacokinetics, August 2012, Springer Science + Business Media

    Dr Catherine Sherwin

  222. Development of population PK model with enterohepatic circulation for mycophenolic acid in patients with childhood‐onset systemic lupus erythematosus

    Article • British Journal of Clinical Pharmacology, April 2012, Wiley

    Dr Catherine Sherwin

  223. The Changing Epidemiology of Invasive Pneumococcal Disease at a Tertiary Children's Hospital Through the 7-valent Pneumococcal Conjugate Vaccine Era

    Article • The Pediatric Infectious Disease Journal, March 2012, Wolters Kluwer Health

    Dr Catherine Sherwin

  224. Maturation of the Glomerular Filtration Rate in Neonates, as Reflected by Amikacin Clearance

    Article • Clinical Pharmacokinetics, February 2012, Springer Science + Business Media

    Professor karel allegaert , Dr Catherine Sherwin

  225. Population Pharmacokinetic and Pharmacodynamic Modeling of High-Dose Intermittent Ticarcillin-Clavulanate Administration in Pediatric Cystic Fibrosis Patients

    Article • Clinical Therapeutics, November 2011, Elsevier

    Dr Catherine Sherwin

  226. Pharmacokinetics of Prednisolone at Steady State in Young Patients With Systemic Lupus Erythematosus on Prednisone Therapy: An Open-Label, Single-Dose Study

    Article • Clinical Therapeutics, October 2011, Elsevier

    Dr Catherine Sherwin

  227. Pharmacokinetics of Levetiracetam in Neonates with Seizures

    Article • The Journal of Pediatrics, July 2011, Elsevier

    Dr Catherine Sherwin

  228. Optimal study design for pioglitazone in septic pediatric patients

    Article • Journal of Pharmacokinetics and Pharmacodynamics, June 2011, Springer Science + Business Media

    Dr Catherine Sherwin

  229. Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid and Their Relation to Response to Therapy of Childhood-Onset Systemic Lupus Erythematosus

    Article • Seminars in Arthritis and Rheumatism, February 2011, Elsevier

    Dr Catherine Sherwin

  230. The Evolution of Population Pharmacokinetic Models to Describe the Enterohepatic Recycling of Mycophenolic Acid in Solid Organ Transplantation and Autoimmune Disease

    Article • Clinical Pharmacokinetics, January 2011, Springer Science + Business Media

    Dr Catherine Sherwin

  231. Individualised dosing of amikacin in neonates

    Article • European Journal of Clinical Pharmacology, August 2009, Springer Science + Business Media

    Dr Catherine Sherwin

  232. Evaluation of the effect of intravenous volume expanders upon the volume of distribution of gentamicin in septic neonates

    Article • Biopharmaceutics & Drug Disposition, June 2009, Wiley

    Dr Catherine Sherwin

  233. Discrepancies between predicted and observed rates of intravenous gentamicin delivery for neonates

    Article • Journal of Pharmacy and Pharmacology, April 2009, Wiley

    Dr Catherine Sherwin

  234. Discrepancies between predicted and observed rates of intravenous gentamicin delivery for neonates

    Article • Journal of Pharmacy and Pharmacology, April 2009, Oxford University Press (OUP)

    Dr Catherine Sherwin

  235. Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis

    Article • European Journal of Clinical Pharmacology, March 2009, Springer Science + Business Media

    Dr Catherine Sherwin

  236. Utility of Interleukin-12 and Interleukin-10 in Comparison with Other Cytokines and Acute-Phase Reactants in the Diagnosis of Neonatal Sepsis

    Article • American Journal of Perinatology, October 2008, Thieme Publishing Group

    Dr Catherine Sherwin

  237. Individualising netilmicin dosing in neonates

    Article • European Journal of Clinical Pharmacology, August 2008, Springer Science + Business Media

    Dr Catherine Sherwin

  238. A simple binding assay for the direct determination of biotin in urine

    Article • Clinica Chimica Acta, October 2005, Elsevier

    Dr Catherine Sherwin

  239. Medication Exposures During Pregnancy and Breastfeeding

    Article • Unmaintained records

    Dr Catherine Sherwin